These patients are treated with trastuzumab, a monoclonal antibody targeting the her2 molecule Even though trastuzumab is an effective therapy, resistance events hamper its clinical benefit, making the development of new therapies a. Nci supports clinical trials that test new and more effective ways to treat cancer Find clinical trials studying trastuzumab. The research team at moffitt developed a groundbreaking vaccine that helps the body’s immune system recognize the her2 protein on breast cancer cells so that it can target and. Review information on clinical studies for herceptin® (trastuzumab) in her2+ adjuvant breast cancer
See full safety and boxed warnings for more information. Abnormal alterations in human epidermal growth factor receptor 2 (her2, neu, and erbb2) are associated with the development of many tumors It is currently a crucial treatment for multiple cancers An increasing number of her2.
OPEN
